APO Research
Talk to an analyst

APO RESEARCH · REPORT

Digital Metabolic Syndrome Management

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Digital Metabolic Syndrome Management Market Analysis and Forecast 2026-2032

12 August 2026184 pages

Choose your research edition.

Industry ResearchDigital Metabolic Syndrome Management Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Digital Metabolic Syndrome Management Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Digital Metabolic Syndrome Management Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Digital Metabolic Syndrome Management Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Digital Metabolic Syndrome Management Market Analysis and Forecast 2026-2032184 pages · $4,950 USD

Market perspective

The global Digital Metabolic Syndrome Management market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Digital Metabolic Syndrome Management is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Digital Metabolic Syndrome Management is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Digital Metabolic Syndrome Management is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Digital Metabolic Syndrome Management is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Digital Metabolic Syndrome Management include Abbott Diabetes Care, Dexcom Inc, Vida Health, Oviva AG, CureApp Inc, Liva Healthcare, Welldoc Inc, Lark Health and Welby Inc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Digital Metabolic Syndrome Management, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Digital Metabolic Syndrome Management, also provides the revenue of main regions and countries. Of the upcoming market potential for Digital Metabolic Syndrome Management, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Digital Metabolic Syndrome Management revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Digital Metabolic Syndrome Management market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Digital Metabolic Syndrome Management revenue, projected growth trends, production technology, application and end-user industry.

Digital Metabolic Syndrome Management Segment by Company

Abbott Diabetes Care

Dexcom Inc

Vida Health

Oviva AG

CureApp Inc

Liva Healthcare

Welldoc Inc

Lark Health

Welby Inc

Hims & Hers Health

WW International

Yidu Tech

Ping An Healthcare

Teladoc Health

Omada Health

Virta Health

Digital Metabolic Syndrome Management Segment by Type

Diabetes Management

Obesity Management

Cardiovascular Risk Management

Fatty Liver and Metabolic Liver Disease Management

Digital Metabolic Syndrome Management Segment by Application

Home-Based Health Management

Hospital-Based Chronic Disease Management

Corporate Employee Health Management

Elderly Health Management

Insurance and Health Service Management

Others

Digital Metabolic Syndrome Management Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Metabolic Syndrome Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digital Metabolic Syndrome Management and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Metabolic Syndrome Management.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Digital Metabolic Syndrome Management in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Digital Metabolic Syndrome Management company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Digital Metabolic Syndrome Management revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Digital Metabolic Syndrome Management Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Diabetes Management Major Player Table 3. Obesity Management Major Player Table 4. Cardiovascular Risk Management Major Player Table 5. Fatty Liver and Metabolic Liver Disease Management Major Player Table 6. Global Digital Metabolic Syndrome Management Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Home-Based Health Management Major Player Table 8. Hospital-Based Chronic Disease Management Major Player Table 9. Corporate Employee Health Management Major Player Table 10. Elderly Health Management Major Player Table 11. Insurance and Health Service Management Major Player Table 12. Others Major Player Table 13. Digital Metabolic Syndrome Management Industry Trends Table 14. Digital Metabolic Syndrome Management Industry Drivers Table 15. Digital Metabolic Syndrome Management Industry Opportunities and Challenges Table 16. Digital Metabolic Syndrome Management Industry Restraints Table 17. Global Digital Metabolic Syndrome Management Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 18. Global Digital Metabolic Syndrome Management Market Size by Region (2021-2026) & (US$ Million) Table 19. Global Digital Metabolic Syndrome Management Market Share by Region (2021-2026) Table 20. Global Digital Metabolic Syndrome Management Market Size by Region (2027-2032) & (US$ Million) Table 21. Global Digital Metabolic Syndrome Management Market Share by Region (2027-2032) Table 22. Global Digital Metabolic Syndrome Management Revenue by Players (US$ Million) & (2021-2026) Table 23. Global Digital Metabolic Syndrome Management Revenue Market Share by Players (2021-2026) Table 24. Global Digital Metabolic Syndrome Management Key Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Digital Metabolic Syndrome Management Key Players Headquarters & Area Served Table 26. Global Digital Metabolic Syndrome Management Players, Product Type & Application Table 27. Global Digital Metabolic Syndrome Management Players Establishment Date Table 28. Global Players Market Concentration Ratio (CR5 and HHI) Table 29. Global Digital Metabolic Syndrome Management by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 30. Global Digital Metabolic Syndrome Management Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Digital Metabolic Syndrome Management Revenue by Type (2021-2026) & (US$ Million) Table 32. Global Digital Metabolic Syndrome Management Revenue by Type (2027-2032) & (US$ Million) Table 33. Global Digital Metabolic Syndrome Management Revenue Market Share by Type (2021-2026) Table 34. Global Digital Metabolic Syndrome Management Revenue Market Share by Type (2027-2032) Table 35. Global Digital Metabolic Syndrome Management Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Digital Metabolic Syndrome Management Revenue by Application (2021-2026) & (US$ Million) Table 37. Global Digital Metabolic Syndrome Management Revenue by Application (2027-2032) & (US$ Million) Table 38. Global Digital Metabolic Syndrome Management Revenue Market Share by Application (2021-2026) Table 39. Global Digital Metabolic Syndrome Management Revenue Market Share by Application (2027-2032) Table 40. Abbott Diabetes Care Company Information Table 41. Abbott Diabetes Care Business Overview Table 42. Abbott Diabetes Care Digital Metabolic Syndrome Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Abbott Diabetes Care Digital Metabolic Syndrome Management Product Portfolio Table 44. Abbott Diabetes Care Recent Development Table 45. Dexcom Inc Company Information Table 46. Dexcom Inc Business Overview Table 47. Dexcom Inc Digital Metabolic Syndrome Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Dexcom Inc Digital Metabolic Syndrome Management Product Portfolio Table 49. Dexcom Inc Recent Development Table 50. Vida Health Company Information Table 51. Vida Health Business Overview Table 52. Vida Health Digital Metabolic Syndrome Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Vida Health Digital Metabolic Syndrome Management Product Portfolio Table 54. Vida Health Recent Development Table 55. Oviva AG Company Information Table 56. Oviva AG Business Overview Table 57. Oviva AG Digital Metabolic Syndrome Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Oviva AG Digital Metabolic Syndrome Management Product Portfolio Table 59. Oviva AG Recent Development Table 60. CureApp Inc Company Information Table 61. CureApp Inc Business Overview Table 62. CureApp Inc Digital Metabolic Syndrome Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. CureApp Inc Digital Metabolic Syndrome Management Product Portfolio Table 64. CureApp Inc Recent Development Table 65. Liva Healthcare Company Information Table 66. Liva Healthcare Business Overview Table 67. Liva Healthcare Digital Metabolic Syndrome Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Liva Healthcare Digital Metabolic Syndrome Management Product Portfolio Table 69. Liva Healthcare Recent Development Table 70. Welldoc Inc Company Information Table 71. Welldoc Inc Business Overview Table 72. Welldoc Inc Digital Metabolic Syndrome Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Welldoc Inc Digital Metabolic Syndrome Management Product Portfolio Table 74. Welldoc Inc Recent Development Table 75. Lark Health Company Information Table 76. Lark Health Business Overview Table 77. Lark Health Digital Metabolic Syndrome Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Lark Health Digital Metabolic Syndrome Management Product Portfolio Table 79. Lark Health Recent Development Table 80. Welby Inc Company Information Table 81. Welby Inc Business Overview Table 82. Welby Inc Digital Metabolic Syndrome Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Welby Inc Digital Metabolic Syndrome Management Product Portfolio Table 84. Welby Inc Recent Development Table 85. Hims & Hers Health Company Information Table 86. Hims & Hers Health Business Overview Table 87. Hims & Hers Health Digital Metabolic Syndrome Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Hims & Hers Health Digital Metabolic Syndrome Management Product Portfolio Table 89. Hims & Hers Health Recent Development Table 90. WW International Company Information Table 91. WW International Business Overview Table 92. WW International Digital Metabolic Syndrome Management Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. WW International Digital Metabolic Syndrome Management Product Portfolio Table 94. WW International Recent Development Table 95. Yidu Tech Company Information Table 96. Yidu Tech Business Overview Table 97. Yidu Tech Digital Metabolic Syndrome Management Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Yidu Tech Digital Metabolic Syndrome Management Product Portfolio Table 99. Yidu Tech Recent Development Table 100. Ping An Healthcare Company Information Table 101. Ping An Healthcare Business Overview Table 102. Ping An Healthcare Digital Metabolic Syndrome Management Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Ping An Healthcare Digital Metabolic Syndrome Management Product Portfolio Table 104. Ping An Healthcare Recent Development Table 105. Teladoc Health Company Information Table 106. Teladoc Health Business Overview Table 107. Teladoc Health Digital Metabolic Syndrome Management Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Teladoc Health Digital Metabolic Syndrome Management Product Portfolio Table 109. Teladoc Health Recent Development Table 110. Omada Health Company Information Table 111. Omada Health Business Overview Table 112. Omada Health Digital Metabolic Syndrome Management Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Omada Health Digital Metabolic Syndrome Management Product Portfolio Table 114. Omada Health Recent Development Table 115. Virta Health Company Information Table 116. Virta Health Business Overview Table 117. Virta Health Digital Metabolic Syndrome Management Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Virta Health Digital Metabolic Syndrome Management Product Portfolio Table 119. Virta Health Recent Development Table 120. North America Digital Metabolic Syndrome Management Revenue by Type (2021-2026) & (US$ Million) Table 121. North America Digital Metabolic Syndrome Management Revenue by Type (2027-2032) & (US$ Million) Table 122. North America Digital Metabolic Syndrome Management Revenue by Application (2021-2026) & (US$ Million) Table 123. North America Digital Metabolic Syndrome Management Revenue by Application (2027-2032) & (US$ Million) Table 124. North America Digital Metabolic Syndrome Management Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. North America Digital Metabolic Syndrome Management Revenue by Country (2021-2026) & (US$ Million) Table 126. North America Digital Metabolic Syndrome Management Revenue by Country (US$ Million) & (2027-2032) Table 127. Europe Digital Metabolic Syndrome Management Revenue by Type (2021-2026) & (US$ Million) Table 128. Europe Digital Metabolic Syndrome Management Revenue by Type (2027-2032) & (US$ Million) Table 129. Europe Digital Metabolic Syndrome Management Revenue by Application (2021-2026) & (US$ Million) Table 130. Europe Digital Metabolic Syndrome Management Revenue by Application (2027-2032) & (US$ Million) Table 131. Europe Digital Metabolic Syndrome Management Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Europe Digital Metabolic Syndrome Management Revenue by Country (2021-2026) & (US$ Million) Table 133. Europe Digital Metabolic Syndrome Management Revenue by Country (US$ Million) & (2027-2032) Table 134. China Digital Metabolic Syndrome Management Revenue by Type (2021-2026) & (US$ Million) Table 135. China Digital Metabolic Syndrome Management Revenue by Type (2027-2032) & (US$ Million) Table 136. China Digital Metabolic Syndrome Management Revenue by Application (2021-2026) & (US$ Million) Table 137. China Digital Metabolic Syndrome Management Revenue by Application (2027-2032) & (US$ Million) Table 138. Asia Digital Metabolic Syndrome Management Revenue by Type (2021-2026) & (US$ Million) Table 139. Asia Digital Metabolic Syndrome Management Revenue by Type (2027-2032) & (US$ Million) Table 140. Asia Digital Metabolic Syndrome Management Revenue by Application (2021-2026) & (US$ Million) Table 141. Asia Digital Metabolic Syndrome Management Revenue by Application (2027-2032) & (US$ Million) Table 142. Asia Digital Metabolic Syndrome Management Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Asia Digital Metabolic Syndrome Management Revenue by Region (US$ Million) & (2021-2026) Table 144. Asia Digital Metabolic Syndrome Management Revenue by Region (US$ Million) & (2027-2032) Table 145. SAMEA Digital Metabolic Syndrome Management Revenue by Type (2021-2026) & (US$ Million) Table 146. SAMEA Digital Metabolic Syndrome Management Revenue by Type (2027-2032) & (US$ Million) Table 147. SAMEA Digital Metabolic Syndrome Management Revenue by Application (2021-2026) & (US$ Million) Table 148. SAMEA Digital Metabolic Syndrome Management Revenue by Application (2027-2032) & (US$ Million) Table 149. SAMEA Digital Metabolic Syndrome Management Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. SAMEA Digital Metabolic Syndrome Management Revenue by Country (2021-2026) & (US$ Million) Table 151. SAMEA Digital Metabolic Syndrome Management Revenue by Country (US$ Million) & (2027-2032) Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Digital Metabolic Syndrome Management Image Figure 2. Global Digital Metabolic Syndrome Management Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Digital Metabolic Syndrome Management Market Size Share 2021 VS 2025 VS 2032 Figure 4. Diabetes Management Image Figure 5. Obesity Management Image Figure 6. Cardiovascular Risk Management Image Figure 7. Fatty Liver and Metabolic Liver Disease Management Image Figure 8. Global Digital Metabolic Syndrome Management Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Digital Metabolic Syndrome Management Market Size Share 2021 VS 2025 VS 2032 Figure 10. Home-Based Health Management Image Figure 11. Hospital-Based Chronic Disease Management Image Figure 12. Corporate Employee Health Management Image Figure 13. Elderly Health Management Image Figure 14. Insurance and Health Service Management Image Figure 15. Others Image Figure 16. Global Digital Metabolic Syndrome Management Market Size (US$ Million) & (2021-2032) Figure 17. Global Digital Metabolic Syndrome Management Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Digital Metabolic Syndrome Management Market Share by Region: 2021 VS 2025 VS 2032 Figure 19. Global Digital Metabolic Syndrome Management Players Revenue Share Top 10 and Top 5 in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Digital Metabolic Syndrome Management Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Digital Metabolic Syndrome Management Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Digital Metabolic Syndrome Management Revenue Market Share by Type (2021-2032) Figure 24. Global Digital Metabolic Syndrome Management Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Digital Metabolic Syndrome Management Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 26. Global Digital Metabolic Syndrome Management Revenue Market Share by Application (2021-2032) Figure 27. North America Digital Metabolic Syndrome Management Revenue YoY Growth (2021-2032) & (US$ Million) Figure 28. North America Digital Metabolic Syndrome Management Revenue Share by Type (2021-2032) Figure 29. North America Digital Metabolic Syndrome Management Revenue Share by Application (2021-2032) Figure 30. North America Digital Metabolic Syndrome Management Revenue Share by Country (2021-2032) Figure 31. United States Digital Metabolic Syndrome Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Canada Digital Metabolic Syndrome Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Mexico Digital Metabolic Syndrome Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Europe Digital Metabolic Syndrome Management Revenue YoY Growth (2021-2032) & (US$ Million) Figure 35. Europe Digital Metabolic Syndrome Management Revenue Share by Type (2021-2032) Figure 36. Europe Digital Metabolic Syndrome Management Revenue Share by Application (2021-2032) Figure 37. Europe Digital Metabolic Syndrome Management Revenue Share by Country (2021-2032) Figure 38. Germany Digital Metabolic Syndrome Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. France Digital Metabolic Syndrome Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. U.K. Digital Metabolic Syndrome Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Italy Digital Metabolic Syndrome Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Spain Digital Metabolic Syndrome Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Russia Digital Metabolic Syndrome Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Netherlands Digital Metabolic Syndrome Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Nordic Countries Digital Metabolic Syndrome Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. China Digital Metabolic Syndrome Management Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. China Digital Metabolic Syndrome Management Revenue Share by Type (2021-2032) Figure 48. China Digital Metabolic Syndrome Management Revenue Share by Application (2021-2032) Figure 49. Asia Digital Metabolic Syndrome Management Revenue YoY Growth (2021-2032) & (US$ Million) Figure 50. Asia Digital Metabolic Syndrome Management Revenue Share by Type (2021-2032) Figure 51. Asia Digital Metabolic Syndrome Management Revenue Share by Application (2021-2032) Figure 52. Asia Digital Metabolic Syndrome Management Revenue Share by Region (2021-2032) Figure 53. Japan Digital Metabolic Syndrome Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. South Korea Digital Metabolic Syndrome Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. India Digital Metabolic Syndrome Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Australia Digital Metabolic Syndrome Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Taiwan Digital Metabolic Syndrome Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Southeast Asia Digital Metabolic Syndrome Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. SAMEA Digital Metabolic Syndrome Management Revenue YoY Growth (2021-2032) & (US$ Million) Figure 60. SAMEA Digital Metabolic Syndrome Management Revenue Share by Type (2021-2032) Figure 61. SAMEA Digital Metabolic Syndrome Management Revenue Share by Application (2021-2032) Figure 62. SAMEA Digital Metabolic Syndrome Management Revenue Share by Country (2021-2032) Figure 63. Brazil Digital Metabolic Syndrome Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Argentina Digital Metabolic Syndrome Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Chile Digital Metabolic Syndrome Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Colombia Digital Metabolic Syndrome Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Peru Digital Metabolic Syndrome Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Saudi Arabia Digital Metabolic Syndrome Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Israel Digital Metabolic Syndrome Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. UAE Digital Metabolic Syndrome Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Turkey Digital Metabolic Syndrome Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Iran Digital Metabolic Syndrome Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Egypt Digital Metabolic Syndrome Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Diabetes Management
  • Obesity Management
  • Cardiovascular Risk Management
  • Fatty Liver and Metabolic Liver Disease Management
Applications
  • Home-Based Health Management
  • Hospital-Based Chronic Disease Management
  • Corporate Employee Health Management
  • Elderly Health Management
  • Insurance and Health Service Management
  • Others
Companies covered
  • Abbott Diabetes Care
  • Dexcom Inc
  • Vida Health
  • Oviva AG
  • CureApp Inc
  • Liva Healthcare
  • Welldoc Inc
  • Lark Health
  • Welby Inc
  • Hims & Hers Health
  • WW International
  • Yidu Tech
  • Ping An Healthcare
  • Teladoc Health
  • Omada Health
  • Virta Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Digital Metabolic Syndrome Management Market by Type
  3. 1.2.1 Global Digital Metabolic Syndrome Management Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Diabetes Management
  5. 1.2.3 Obesity Management
  6. 1.2.4 Cardiovascular Risk Management
  7. 1.2.5 Fatty Liver and Metabolic Liver Disease Management
  8. 1.3 Digital Metabolic Syndrome Management Market by Application
  9. 1.3.1 Global Digital Metabolic Syndrome Management Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Home-Based Health Management
  11. 1.3.3 Hospital-Based Chronic Disease Management
  12. 1.3.4 Corporate Employee Health Management
  13. 1.3.5 Elderly Health Management
  14. 1.3.6 Insurance and Health Service Management
  15. 1.3.7 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Digital Metabolic Syndrome Management Market Dynamics
  1. 2.1 Digital Metabolic Syndrome Management Industry Trends
  2. 2.2 Digital Metabolic Syndrome Management Industry Drivers
  3. 2.3 Digital Metabolic Syndrome Management Industry Opportunities and Challenges
  4. 2.4 Digital Metabolic Syndrome Management Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Digital Metabolic Syndrome Management Market Perspective (2021-2032)
  2. 3.2 Global Digital Metabolic Syndrome Management Growth Trends by Region
  3. 3.2.1 Global Digital Metabolic Syndrome Management Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Digital Metabolic Syndrome Management Market Size by Region (2021-2026)
  5. 3.2.3 Global Digital Metabolic Syndrome Management Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Digital Metabolic Syndrome Management Revenue by Players
  2. 4.1.1 Global Digital Metabolic Syndrome Management Revenue by Players (2021-2026)
  3. 4.1.2 Global Digital Metabolic Syndrome Management Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Digital Metabolic Syndrome Management Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Digital Metabolic Syndrome Management Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Digital Metabolic Syndrome Management Key Players Headquarters & Area Served
  7. 4.4 Global Digital Metabolic Syndrome Management Players, Product Type & Application
  8. 4.5 Global Digital Metabolic Syndrome Management Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Digital Metabolic Syndrome Management Market CR5 and HHI
  11. 4.6.3 2025 Digital Metabolic Syndrome Management Tier 1, Tier 2, and Tier 3
5 Digital Metabolic Syndrome Management Market Size by Type
  1. 5.1 Global Digital Metabolic Syndrome Management Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Digital Metabolic Syndrome Management Revenue by Type (2021-2032)
  3. 5.3 Global Digital Metabolic Syndrome Management Revenue Market Share by Type (2021-2032)
6 Digital Metabolic Syndrome Management Market Size by Application
  1. 6.1 Global Digital Metabolic Syndrome Management Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Digital Metabolic Syndrome Management Revenue by Application (2021-2032)
  3. 6.3 Global Digital Metabolic Syndrome Management Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Abbott Diabetes Care
  2. 7.1.1 Abbott Diabetes Care Company Information
  3. 7.1.2 Abbott Diabetes Care Business Overview
  4. 7.1.3 Abbott Diabetes Care Digital Metabolic Syndrome Management Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Diabetes Care Digital Metabolic Syndrome Management Product Portfolio
  6. 7.1.5 Abbott Diabetes Care Recent Developments
  7. 7.2 Dexcom Inc
  8. 7.2.1 Dexcom Inc Company Information
  9. 7.2.2 Dexcom Inc Business Overview
  10. 7.2.3 Dexcom Inc Digital Metabolic Syndrome Management Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Dexcom Inc Digital Metabolic Syndrome Management Product Portfolio
  12. 7.2.5 Dexcom Inc Recent Developments
  13. 7.3 Vida Health
  14. 7.3.1 Vida Health Company Information
  15. 7.3.2 Vida Health Business Overview
  16. 7.3.3 Vida Health Digital Metabolic Syndrome Management Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Vida Health Digital Metabolic Syndrome Management Product Portfolio
  18. 7.3.5 Vida Health Recent Developments
  19. 7.4 Oviva AG
  20. 7.4.1 Oviva AG Company Information
  21. 7.4.2 Oviva AG Business Overview
  22. 7.4.3 Oviva AG Digital Metabolic Syndrome Management Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Oviva AG Digital Metabolic Syndrome Management Product Portfolio
  24. 7.4.5 Oviva AG Recent Developments
  25. 7.5 CureApp Inc
  26. 7.5.1 CureApp Inc Company Information
  27. 7.5.2 CureApp Inc Business Overview
  28. 7.5.3 CureApp Inc Digital Metabolic Syndrome Management Revenue and Gross Margin (2021-2026)
  29. 7.5.4 CureApp Inc Digital Metabolic Syndrome Management Product Portfolio
  30. 7.5.5 CureApp Inc Recent Developments
  31. 7.6 Liva Healthcare
  32. 7.6.1 Liva Healthcare Company Information
  33. 7.6.2 Liva Healthcare Business Overview
  34. 7.6.3 Liva Healthcare Digital Metabolic Syndrome Management Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Liva Healthcare Digital Metabolic Syndrome Management Product Portfolio
  36. 7.6.5 Liva Healthcare Recent Developments
  37. 7.7 Welldoc Inc
  38. 7.7.1 Welldoc Inc Company Information
  39. 7.7.2 Welldoc Inc Business Overview
  40. 7.7.3 Welldoc Inc Digital Metabolic Syndrome Management Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Welldoc Inc Digital Metabolic Syndrome Management Product Portfolio
  42. 7.7.5 Welldoc Inc Recent Developments
  43. 7.8 Lark Health
  44. 7.8.1 Lark Health Company Information
  45. 7.8.2 Lark Health Business Overview
  46. 7.8.3 Lark Health Digital Metabolic Syndrome Management Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Lark Health Digital Metabolic Syndrome Management Product Portfolio
  48. 7.8.5 Lark Health Recent Developments
  49. 7.9 Welby Inc
  50. 7.9.1 Welby Inc Company Information
  51. 7.9.2 Welby Inc Business Overview
  52. 7.9.3 Welby Inc Digital Metabolic Syndrome Management Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Welby Inc Digital Metabolic Syndrome Management Product Portfolio
  54. 7.9.5 Welby Inc Recent Developments
  55. 7.10 Hims & Hers Health
  56. 7.10.1 Hims & Hers Health Company Information
  57. 7.10.2 Hims & Hers Health Business Overview
  58. 7.10.3 Hims & Hers Health Digital Metabolic Syndrome Management Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Hims & Hers Health Digital Metabolic Syndrome Management Product Portfolio
  60. 7.10.5 Hims & Hers Health Recent Developments
  61. 7.11 WW International
  62. 7.11.1 WW International Company Information
  63. 7.11.2 WW International Business Overview
  64. 7.11.3 WW International Digital Metabolic Syndrome Management Revenue and Gross Margin (2021-2026)
  65. 7.11.4 WW International Digital Metabolic Syndrome Management Product Portfolio
  66. 7.11.5 WW International Recent Developments
  67. 7.12 Yidu Tech
  68. 7.12.1 Yidu Tech Company Information
  69. 7.12.2 Yidu Tech Business Overview
  70. 7.12.3 Yidu Tech Digital Metabolic Syndrome Management Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Yidu Tech Digital Metabolic Syndrome Management Product Portfolio
  72. 7.12.5 Yidu Tech Recent Developments
  73. 7.13 Ping An Healthcare
  74. 7.13.1 Ping An Healthcare Company Information
  75. 7.13.2 Ping An Healthcare Business Overview
  76. 7.13.3 Ping An Healthcare Digital Metabolic Syndrome Management Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Ping An Healthcare Digital Metabolic Syndrome Management Product Portfolio
  78. 7.13.5 Ping An Healthcare Recent Developments
  79. 7.14 Teladoc Health
  80. 7.14.1 Teladoc Health Company Information
  81. 7.14.2 Teladoc Health Business Overview
  82. 7.14.3 Teladoc Health Digital Metabolic Syndrome Management Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Teladoc Health Digital Metabolic Syndrome Management Product Portfolio
  84. 7.14.5 Teladoc Health Recent Developments
  85. 7.15 Omada Health
  86. 7.15.1 Omada Health Company Information
  87. 7.15.2 Omada Health Business Overview
  88. 7.15.3 Omada Health Digital Metabolic Syndrome Management Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Omada Health Digital Metabolic Syndrome Management Product Portfolio
  90. 7.15.5 Omada Health Recent Developments
  91. 7.16 Virta Health
  92. 7.16.1 Virta Health Company Information
  93. 7.16.2 Virta Health Business Overview
  94. 7.16.3 Virta Health Digital Metabolic Syndrome Management Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Virta Health Digital Metabolic Syndrome Management Product Portfolio
  96. 7.16.5 Virta Health Recent Developments
8 North America
  1. 8.1 North America Digital Metabolic Syndrome Management Revenue (2021-2032)
  2. 8.2 North America Digital Metabolic Syndrome Management Revenue by Type (2021-2032)
  3. 8.2.1 North America Digital Metabolic Syndrome Management Revenue by Type (2021-2026)
  4. 8.2.2 North America Digital Metabolic Syndrome Management Revenue by Type (2027-2032)
  5. 8.3 North America Digital Metabolic Syndrome Management Revenue Share by Type (2021-2032)
  6. 8.4 North America Digital Metabolic Syndrome Management Revenue by Application (2021-2032)
  7. 8.4.1 North America Digital Metabolic Syndrome Management Revenue by Application (2021-2026)
  8. 8.4.2 North America Digital Metabolic Syndrome Management Revenue by Application (2027-2032)
  9. 8.5 North America Digital Metabolic Syndrome Management Revenue Share by Application (2021-2032)
  10. 8.6 North America Digital Metabolic Syndrome Management Revenue by Country
  11. 8.6.1 North America Digital Metabolic Syndrome Management Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Digital Metabolic Syndrome Management Revenue by Country (2021-2026)
  13. 8.6.3 North America Digital Metabolic Syndrome Management Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Digital Metabolic Syndrome Management Revenue (2021-2032)
  2. 9.2 Europe Digital Metabolic Syndrome Management Revenue by Type (2021-2032)
  3. 9.2.1 Europe Digital Metabolic Syndrome Management Revenue by Type (2021-2026)
  4. 9.2.2 Europe Digital Metabolic Syndrome Management Revenue by Type (2027-2032)
  5. 9.3 Europe Digital Metabolic Syndrome Management Revenue Share by Type (2021-2032)
  6. 9.4 Europe Digital Metabolic Syndrome Management Revenue by Application (2021-2032)
  7. 9.4.1 Europe Digital Metabolic Syndrome Management Revenue by Application (2021-2026)
  8. 9.4.2 Europe Digital Metabolic Syndrome Management Revenue by Application (2027-2032)
  9. 9.5 Europe Digital Metabolic Syndrome Management Revenue Share by Application (2021-2032)
  10. 9.6 Europe Digital Metabolic Syndrome Management Revenue by Country
  11. 9.6.1 Europe Digital Metabolic Syndrome Management Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Digital Metabolic Syndrome Management Revenue by Country (2021-2026)
  13. 9.6.3 Europe Digital Metabolic Syndrome Management Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Digital Metabolic Syndrome Management Revenue (2021-2032)
  2. 10.2 China Digital Metabolic Syndrome Management Revenue by Type (2021-2032)
  3. 10.2.1 China Digital Metabolic Syndrome Management Revenue by Type (2021-2026)
  4. 10.2.2 China Digital Metabolic Syndrome Management Revenue by Type (2027-2032)
  5. 10.3 China Digital Metabolic Syndrome Management Revenue Share by Type (2021-2032)
  6. 10.4 China Digital Metabolic Syndrome Management Revenue by Application (2021-2032)
  7. 10.4.1 China Digital Metabolic Syndrome Management Revenue by Application (2021-2026)
  8. 10.4.2 China Digital Metabolic Syndrome Management Revenue by Application (2027-2032)
  9. 10.5 China Digital Metabolic Syndrome Management Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Digital Metabolic Syndrome Management Revenue (2021-2032)
  2. 11.2 Asia Digital Metabolic Syndrome Management Revenue by Type (2021-2032)
  3. 11.2.1 Asia Digital Metabolic Syndrome Management Revenue by Type (2021-2026)
  4. 11.2.2 Asia Digital Metabolic Syndrome Management Revenue by Type (2027-2032)
  5. 11.3 Asia Digital Metabolic Syndrome Management Revenue Share by Type (2021-2032)
  6. 11.4 Asia Digital Metabolic Syndrome Management Revenue by Application (2021-2032)
  7. 11.4.1 Asia Digital Metabolic Syndrome Management Revenue by Application (2021-2026)
  8. 11.4.2 Asia Digital Metabolic Syndrome Management Revenue by Application (2027-2032)
  9. 11.5 Asia Digital Metabolic Syndrome Management Revenue Share by Application (2021-2032)
  10. 11.6 Asia Digital Metabolic Syndrome Management Revenue by Country
  11. 11.6.1 Asia Digital Metabolic Syndrome Management Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Digital Metabolic Syndrome Management Revenue by Country (2021-2026)
  13. 11.6.3 Asia Digital Metabolic Syndrome Management Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Digital Metabolic Syndrome Management Revenue (2021-2032)
  2. 12.2 SAMEA Digital Metabolic Syndrome Management Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Digital Metabolic Syndrome Management Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Digital Metabolic Syndrome Management Revenue by Type (2027-2032)
  5. 12.3 SAMEA Digital Metabolic Syndrome Management Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Digital Metabolic Syndrome Management Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Digital Metabolic Syndrome Management Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Digital Metabolic Syndrome Management Revenue by Application (2027-2032)
  9. 12.5 SAMEA Digital Metabolic Syndrome Management Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Digital Metabolic Syndrome Management Revenue by Country
  11. 12.6.1 SAMEA Digital Metabolic Syndrome Management Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Digital Metabolic Syndrome Management Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Digital Metabolic Syndrome Management Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst